NFA
LOXO

Nationwide Fund Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Nationwide Fund Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,188
Closed -$2.23M – 2859
2017
Q3 		$2.23M Sell
24,188
-13,661
-36% -$1.06M 0.01% 1400
2017
Q2 		$3.04M Buy
37,849
+10,415
+38% +$577K 0.01% 1255
2017
Q1 		$1.15M Buy
27,434
+6,632
+32% +$273K ﹤0.01% 1667
2016
Q4 		$668K Sell
20,802
-1,090
-5% -$27.9K ﹤0.01% 2003
2016
Q3 		$573K Sell
21,892
-1,500
-6% -$39.2K ﹤0.01% 2113
2016
Q2 		$542K Buy
23,392
+17,775
+316% +$443K ﹤0.01% 2110
2016
Q1 		$154K Sell
5,617
-27
-0.5% -$565 ﹤0.01% 2647
2015
Q4 		$161K Sell
5,644
-9,314
-62% -$250K ﹤0.01% 2648
2015
Q3 		$261K Hold
14,958
– – ﹤0.01% 2435
2015
Q2 		$270K Buy
14,958
+2,405
+19% +$32.9K ﹤0.01% 2554
2015
Q1 		$156K Hold
12,553
– – ﹤0.01% 2815
2014
Q4 		$147K Buy
12,553
+5,428
+76% +$63.2K ﹤0.01% 2787
2014
Q3 		$94K Buy
+7,125
New +$92.4K ﹤0.01% 3008

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Nationwide Fund Advisors's LOXO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 24,188 shares — an estimated $2.23M sold.

Nationwide Fund Advisors first reported a position in LOXO in Q3 2014 and held it in 13 quarters. The position peaked at $3.04M in Q2 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 24,188 Loxo Oncology, Inc shares in Q4 2017, an estimated $2.23M.
  • Nationwide Fund Advisors first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 13 quarters.
  • Nationwide Fund Advisors's Loxo Oncology, Inc position peaked at $3.04M in Q2 2017.
  • 141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.